Pulmonary Center and the Section of Pulmonary and Critical Care Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Am Heart J. 2013 Jun;165(6):949-955.e3. doi: 10.1016/j.ahj.2013.03.020. Epub 2013 Apr 25.
Newly diagnosed atrial fibrillation (AF) during severe sepsis is associated with increased risks of in-hospital stroke and mortality. However, the prevalence, incidence, and risk factors associated with AF during the sepsis syndromes are unclear.
We identified patients with preexisting, newly diagnosed, or no AF in a nationally representative 5% sample of Medicare beneficiaries hospitalized with sepsis between 2004 and 2007. We identified multivariable-adjusted demographic and clinical characteristics associated with development of newly diagnosed AF during a sepsis hospitalization.
A total of 60,209 beneficiaries had a sepsis hospitalization. Mean age was 80.2 years, 44.4% were men, and 83.1% were white. Atrial fibrillation occurred during 25.5% (95% CI 25.2-25.9) of sepsis hospitalizations, including 18.3% (18.0%-18.7%) with preexisting AF and 7.2% (7.0%-7.4%) with newly diagnosed AF. Patients with sepsis requiring intensive care had a greater risk of newly diagnosed AF (10.7%, 95% CI 10.3%-11.1%) compared with patients who did not require intensive care (4.4%, 4.2%-4.5%, P < .001). In multivariable analysis, factors associated with newly diagnosed AF during sepsis included older age, white race, acute organ dysfunction, intensive care unit admission, mechanical ventilation, right heart catheterization, diagnosis of endocarditis, and coronary artery bypass graft surgery. Cardiovascular comorbid conditions generally were not associated with increased risk for newly diagnosed AF during sepsis.
Atrial fibrillation is common among critically ill patients with sepsis. Acute factors, rather than preexisting cardiovascular comorbid conditions, are associated with increased risk for newly diagnosed AF during sepsis, suggesting that mechanisms of newly diagnosed AF during sepsis may differ from the general population of patients with AF.
严重脓毒症期间新发心房颤动(AF)与住院期间中风和死亡风险增加相关。然而,脓毒症综合征期间 AF 的患病率、发病率和相关危险因素尚不清楚。
我们在 2004 年至 2007 年间,从 Medicare 受益人群中 5%的代表性样本中确定了患有脓毒症且存在、新发或无 AF 的患者。我们确定了与脓毒症住院期间新发 AF 发展相关的多变量调整后的人口统计学和临床特征。
共有 60209 名受益人因脓毒症住院。平均年龄为 80.2 岁,44.4%为男性,83.1%为白人。心房颤动发生在 25.5%(95%CI 25.2-25.9)的脓毒症住院患者中,包括 18.3%(18.0%-18.7%)为既往有 AF,7.2%(7.0%-7.4%)为新发 AF。需要重症监护的脓毒症患者新发 AF 的风险更高(10.7%,95%CI 10.3%-11.1%),而无需重症监护的患者为 4.4%(4.2%-4.5%,P<.001)。多变量分析显示,脓毒症期间新发 AF 的相关因素包括年龄较大、白种人、急性器官功能障碍、入住重症监护病房、机械通气、右心导管检查、心内膜炎诊断和冠状动脉旁路移植术。心血管合并症通常与脓毒症期间新发 AF 的风险增加无关。
在患有脓毒症的危重症患者中,AF 很常见。急性因素而非预先存在的心血管合并症与脓毒症期间新发 AF 的风险增加相关,这表明脓毒症期间新发 AF 的机制可能与 AF 一般人群不同。